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Inflammatory myofibroblastic tumor is a rare benign lesion whose tumor origin is now proven. It represents 0.7% of
all lung tumors. We report the case of a three-year-old child who suffered from a chronic cough with recurrent
respiratory infections. Chest X-ray and computed tomography revealed the presence of a left lower lobe lung mass.
After pneumonectomy, histological examination combined with immunohistochemical study discovered an
inflammatory myofibroblastic tumor.
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
8722069326962972.
Keywords: Inflammatory myofibroblastic tumor, Lung, ChildIntroduction
Inflammatory myofibroblastic tumor (IMT) is a rare be-
nign tumor, accounting for 0.7% of all lung tumors. [1,2]
It has been first described by Brunn in 1939. [3] Its ori-
gin is unknown, but recent studies have shown that it is
a true tumor rather than a reaction process. [1,4]
Its clinical and radiological manifestations are diverse
and non specific. That’s why diagnosis is difficult to es-
tablish unless a surgical resection is performed. [2,5]
Through this observation, the authors recall the radio-
clinical, histopathological, therapeutic aspects, and out-
come of this rare tumor.Case report
We report the case of a three-year-old child, who has
had a chronic cough with recurrent respiratory infec-
tions since the age of 1 year.
Chest X-ray showed a homogenous opacity invading
the entire left hemithorax. Chest computed tomography
(CT) scan showed a left lower lobe tumor with a small
calcification, associated with upper lobe atelectasis.
This attracted the mediastinum content to the left side
(Figure 1). Bronchoscopy showed a complete obstruction* Correspondence: nawal-h111@hotmail.com
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reproduction in any medium, provided the orof the left main bronchus. The resort to surgery was for
diagnostic and therapeutic purposes, and consisted of a
left pneumonectomy. On gross examination, the tumor
was 8.5 cm in size, firm, whitish and homogeneous.
Microscopic examination revealed a proliferation of regu-
lar spindle cells arrayed in fascicles, admixed with lym-
phocytes, plasma cells and eosinophils (Figures 2 and 3).
Immunohistochemical analysis showed positive staining
for ALK1 (Figure 4), smooth muscle actin (Figure 5), and
H-caldesmon. In contrast, the tumor cells were not react-
ive to PS100. Based on these data, the diagnosis of inflam-
matory myofibroblastic tumor was retained.Discussion
The IMT is a rare benign lesion representing 0.7% of all
lung tumors. It was previously called inflammatory pseu-
dotumor, plasma cell granuloma, histiocytoma or fibrox-
anthoma. [1,2,5,6] It was first described in the lung in
1939 but other extrapulmonary sites were reported
[2,4,6]. Völker and al [7] reported a laryngeal IMT and
compared it with spindle cell carcinoma. Because of
similar morphology of theses lesions, only immunohisto-
chemical investigations allowed the correct final diagno-
ses. Another case was reported in the urinary bladder by
Lekas and al [8]. It was initially misinterpreted as a low-
grade leiomyosarcoma of myxoid subtype. Al-Jabri [9]
reported another case in the liver in which imagingal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chest Computed tomography axial cuts with
parenchymal (A) and mediastinal (B) window showing a left
lower lobe tumor containing a small calcification, associated
with upper lobe atelectasis. The whole is responsible for the
attraction of the mediastinum content to the left side.
Figure 3 Proliferation of regular myofibroblasts mixed with
lymphocytes and plasma cells (high magnification).
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of the similarity of appearances between the two patho-
logical entities. Histological examination was necessary
for diagnosis. Several other sites were reported including
spleen, lymph nodes, esophagus, stomach, salivary
glands, breast, epididymis, central nervous system, and
soft tissues. [2,4,6] The IMT affects both sexes, at any
ages, with a slight predominance in children and young
adults. [4,6] In our patient, the tumor was discovered at
a very early age.
There are many uncertainties about the pathogenesis
of IMT. Several hypotheses have been proposed such as
an auto-immune mechanism or infectious origin. Indeed,
30% of cases are closely related to recurrent respiratory
infections which are caused by several microorganisms
such as Mycoplasma, Nocardia, Actinomycetes, Epstein-
Barr and human herpes virus [2,3,5,6,10]. Other studies,
however, suggest that it might be a true neoplasm due to
the presence, at the myofibroblastic component, of a fu-
sion gene involving the ALK gene, a tyrosine kinase
oncogen located on chromosome 2p23, initially found to
be arranged in anaplasic large cell lymphomas. This fu-
sion leads to constitutive overexpression of the ALK,Figure 2 Spindle cells arrayed in fascicles, mixed with
inflammatory cells (medium magnification).causing cell proliferation. [4-6,10,11] In our patient, the
tumor is due to overexpression of the ALK, detected by
immunohistochemistry, and is probably favored by recur-
rent respiratory infections.
Patients are afflicted with nonspecific symptoms such
as cough, dyspnea, hemoptysis, chest pain, fever and fa-
tigue. Weight loss and anorexia are rare. [2-6] However,
most patients are asymptomatic and the tumor is discov-
ered incidentally on a chest X-ray performed for another
reason. [1,4,6] The only symptom in our patient was a
chronic cough.
Radiological aspects are variable and nonspecific. Most
patients (87%) have a mass or a pulmonary nodule, soli-
tary, rarely multiple (5%), measuring 1 to 6 cm in diam-
eter, sharply limited, smooth or bumpy. The lesion is
located on the periphery with a predilection for the
lower lobes. [2,4,6]
Computed tomography shows the presence of a het-
erogeneous nodule or mass with variable contrast en-
hancement. It specifies the tissue or cystic nature of the
tumor, its vascular behavior and it assesses theFigure 4 Immunohistochemical study showing reactivity for
ALK1.
Figure 5 Immunohistochemical study showing reactivity for
AML.
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http://www.diagnosticpathology.org/content/7/1/83locoregional extension. Calcifications and cavitations are
rare. Pleural effusion is seen in less than 10% and atelec-
tasis in 8% of cases. Sometimes the tumor can extend to-
wards the hilum, mediastinum, pleura or diaphragm.
[1,2]
The treatment of choice for diagnostic and therapeutic
reasons is a complete resection. An incomplete resection
increases the risk of recurrence. [1-3,5] Corticosteroids
are generally not useful in adults, although good results
have been reported in children in cases of unresectable
tumors or hilar and mediastinal invasion. Chemotherapy
is useful in cases of multifocal, invasive lesions or in
cases of local recurrence. [2]
On gross examination, the tumor is well circumscribed
but not encapsulated, firm and homogeneous, with
sometimes some foci of necrosis. [10]
Because of the diversity of clinical and radiological
manifestations of IMT, diagnosis is difficult to establish
without chirurgical management. It is therefore based on
histological examination of the chirurgical resection spe-
cimen that shows a lesion formed of varying proportions
of spindle cells of myofibroblastic type, arranged in a fi-
brous, myxoid or calcified stroma, associated with an in-
flammatory component predominantly lymphocytic and
plasmacytic, with a variable component of eosinophils.
[2,4,5,10]
IMT includes three histological subtypes: one is a
richly vascularized and myxoïde resembling fasciitis or
granulation tissue; onother is a more compact fascicular
spindle cell proliferation with variable collagenized
regions and lymphoid nodules, resembling fibromatosis,
and finally a very sclero-hyaline, slightly cellular pattern,
looking more like a desmoid tumor. [4]
Immunohistochemistry showed reactivity for vimentin
and smooth muscle actin. Immunohistochemical positiv-
ity for ALK is detectable in just over half of the cases
with cytoplasmic staining, more rarely at the nuclear
membrane. [10,11]Pathologic differential diagnosis includes organized
pneumonia, lymphoma and solitary fibrous tumor. The
mode of tumor growth, the low mitotic index, the poly-
clonality of lymphoid markers and the negativity of
CD34 usually remove most of these diagnoses. Other
differential diagnoses are desmoid fibromatosis, angio-
myofibroblastoma, fibrosarcoma, leiomyoma, and malig-
nant fibrous histiocytoma. [2,4]
Despite IMT is a benign tumor, it is considered by
some authors as a low grade tumor because of malig-
nant features such as local invasiveness, recurrence
(4% in cases of incomplete resection) or malignant
transformation (exceptional). The evolution depends
on the tumor size (less than or equal to 3 cm) and
the quality of surgical resection. The 5-year survival is
91.3%. [2-5].
Conclusions
Inflammatory myofibroblastic tumor is a rare benign
tumor. Clinical and radiological presentation is variable
and nonspecific and the diagnosis is rarely made before
chirurgical management. Only histological and immuno-
histochemical study can confirm the diagnosis. Despite
being a benign lesion, its potential for recurrence and
local invasion requires complete surgical resection.
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